help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 7, 2009
Molecular Endocrinology, doi:10.1210/me.2008-0217
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
23/8/1255    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boumah, C. E.
Right arrow Articles by Partridge, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boumah, C. E.
Right arrow Articles by Partridge, N. C.

Submitted on July 2, 2008
Accepted on April 28, 2009

Runx2 Recruits p300 to Mediate Parathyroid Hormone's Effects on Histone Acetylation and Transcriptional Activation of the Matrix Metalloproteinase-13 Gene

Christine E. Boumah, Minnkyong Lee, Nagarajan Selvamurugan, Emi Shimizu, and Nicola C. Partridge*

Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA; Department of Endocrinology, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras Taramani, Chennai 600 113, India

* To whom correspondence should be addressed. E-mail: partrinc{at}umdnj.edu.

Parathyroid hormone (PTH) regulates transcription of a number of genes involved in bone remodeling and calcium homeostasis. We have previously shown that the matrix metalloproteinase-13 (MMP-13) gene is induced by PTH in osteoblastic cells as a secondary response through the PKA pathway requiring the RD and AP-1 binding sites of the proximal promoter. Here, we investigated the changes PTH causes in histone acetylation in this region (which contains the only DNase hypersensitive sites in the promoter) leading to MMP-13 gene activation in these cells. Chromatin immunoprecipitation (ChIP) experiments revealed that PTH rapidly increased histone H4 acetylation followed by histone H3 acetylation associated with the different regions of the MMP-13 proximal promoter. The hormone also stimulated p300 histone acetyl transferase activity, and increased p300 bound to the MMP-13 proximal promoter and this required protein synthesis. Upon PTH treatment, Runx2, already bound to the RD site of the MMP-13 promoter, interacted with p300, which then acetylated histones H4 and H3. The knockdown of either Runx2 or p300 by RNA interference reduced PTH-induced acetylation of histones H3 and H4, association of p300 with the MMP-13 promoter, and resultant MMP-13 gene transcription. Overall, our studies suggest that without altering the gross chromatin structure, PTH stimulates acetylation of histones H3 and H4 via recruitment of p300 to Runx2 bound to the MMP-13 promoter, resulting in gene activation. This work establishes the molecular basis of transcriptional regulation in osteoblasts by PTH, a hormone acting through a G-protein coupled receptor.


Key words: Runx2 • p300 • parathyroid hormone • matrix metalloproteinase-13 • osteoblast transcription

NURSA Molecule Pages Link:

Coregulators:   p300






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society